Transplant-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized
complication of hematopoietic stem cell transplant (HSCT) with high morbidity and mortality …

Haemolytic uraemic syndrome (HUS) is a heterogeneous group of diseases that result in a
common pathology, thrombotic microangiopathy, which is classically characterised by the …

Transplantation-associated thrombotic microangiopathy (TA-TMA) is an increasingly
recognized complication of hematopoietic cell transplantation (HCT) associated with …

Abstract Coronavirus disease-2019 (COVID-19) is a rapidly evolving health crisis caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a novel …

Advances in conditioning, graft-versus-host disease (GVHD) prophylaxis and antimicrobial
prophylaxis have improved the safety of allogeneic hematopoietic cell transplantation (HCT) …

The syndrome of thrombotic microangiopathy (TMA) is a clinical-pathological entity
characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end organ …

Thrombotic microangiopathies (TMA) constitute a group of different disorders that have a
common underlying mechanism: the endothelial damage. These disorders may exhibit …

Background Transplant-associated thrombotic microangiopathy (TA-TMA) is a dangerous
and life-threatening complication in patients undergoing hematopoietic stem cell …

Acute kidney injury (AKI) is a common complication of allogeneic hematopoietic cell
transplantation (allo-HCT) and is associated with non-relapse mortality (NRM) and quality of …

The thrombotic microangiopathies (TMAs) are a heterogenous group of disorders with
distinct pathophysiologies that cause occlusive microvascular or macrovascular thrombosis …